SC
TMDX icon

Stephens Consulting’s Transmedics TMDX Stock Holding History

Stephens Consulting’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1
Closed -$135 – 1087
2025
Q2 		$135 Sell
1
-9
-90% -$988 ﹤0.01% 1057
2025
Q1 		$673 Buy
+10
New +$688 ﹤0.01% 846
2024
Q3 		– Sell
-23
Closed -$3.46K – 643
2024
Q2 		$3.46K Buy
+23
New +$2.76K ﹤0.01% 449

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Stephens Consulting's TMDX Position: Q3 2025 in Review

Stephens Consulting sold out of Transmedics (TMDX) in Q3 2025, closing a stake of 1 share — an estimated $135 sold.

Stephens Consulting first reported a position in TMDX in Q2 2024 and held it in 3 quarters. The position peaked at $3.46K in Q2 2024. 388 funds tracked by Wall St. Rank hold TMDX as of Q3 2025.

  • Stephens Consulting reported no remaining Transmedics position as of Q3 2025 after selling out during the quarter.
  • Stephens Consulting sold 1 Transmedics share in Q3 2025, an estimated $135.
  • Stephens Consulting first reported a position in Transmedics in Q2 2024 and held it in 3 quarters.
  • Stephens Consulting's Transmedics position peaked at $3.46K in Q2 2024.
  • 388 funds tracked by Wall St. Rank held Transmedics as of Q3 2025.

Based on Stephens Consulting's 13F filing for Q3 2025, filed 15 Oct 2025.